Evaluation Of Anemia After Long-Term Treatment With Imatinib In Chronic Myeloid Leukemia In Chronic Phase

被引：0
|
作者：
Moura, Muriel Silva
Pagnano, Katia B.
Benevides, Thais
De Souza, Carmino A., Sr.
Lorand-Metze, Irene
Delamain, Marcia T.
Duarte, Gislaine O.
Pericole, Fernando V.
Percout, Priscila
Dias, Maria
Duarte, Bruno
Campos, Paula
Assuncao, Paola
Oliveira, Luciene
Paul, Pamela
Fernandes, Eliana
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.5200.5200
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5200
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Evaluation of anemia after long-term treatment with imatinib in chronic myeloid leukemia patients in chronic phase
    Moura, Muriel Silva
    Benevides, Thais Celi Lopes
    Delamain, Marcia Torresan
    Duarte, Gislaine Oliveira
    Percout, Priscila Oliveira
    Dias, Maria Almeida
    Zulli, Roberto
    Souza, Carmino Antonio de
    Lorand-Metze, Irene
    Pagnano, Katia Borgia Barbosa
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2019, 41 (04) : 329 - 334
  • [2] CAUSES OF ANEMIA AFTER LONG-TERM TREATMENT WITH IMATINIB IN CHRONIC MYELOID LEUKEMIA
    Lorand-Metze, I.
    Moura, M. S.
    Benevides, T. C.
    Delamain, M. T.
    Pagnano, K. B.
    HAEMATOLOGICA, 2014, 99 : 599 - 599
  • [3] Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia
    Hochhaus, Andreas
    Larson, Richard A.
    Guilhot, Francois
    Radich, Jerald P.
    Branford, Susan
    Hughes, Timothy P.
    Baccarani, Michele
    Deininger, Michael W.
    Cervantes, Francisco
    Fujihara, Satoko
    Ortmann, Christine-Elke
    Menssen, Hans D.
    Kantarjian, Hagop
    O'Brien, Stephen G.
    Druker, Brian J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (10): : 917 - 927
  • [4] LONG-TERM BOSUTINIB IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML) AFTER PRIOR IMATINIB FAILURE
    Bruemmendorf, T. H.
    Cortes, J. E.
    Khoury, H. J.
    Kantarjian, H. M.
    Kim, D. -W.
    Schafhausen, P.
    Zeremski, M.
    Bardy-Bouxin, N.
    Shapiro, M.
    Leip, E.
    Gambacorti-Passerini, C.
    Lipton, J. H.
    HAEMATOLOGICA, 2015, 100 : 232 - 232
  • [5] Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib
    Cortes, Jorge E.
    Khoury, Hanna J.
    Kantarjian, Hagop M.
    Lipton, Jeff H.
    Kim, Dong-Wook
    Schafhausen, Philippe
    Matczak, Ewa
    Leip, Eric
    Noonan, Kay
    Bruemmendorf, Tim H.
    Gambacorti-Passerini, Carlo
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (12) : 1206 - 1214
  • [6] Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase
    Mughal, Tariq I.
    Schrieber, Andrew
    BIOLOGICS-TARGETS & THERAPY, 2010, 4 : 315 - 323
  • [7] Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomes
    Stagno, Fabio
    Stella, Stefania
    Spitaleri, Antonio
    Pennisi, Maria Stella
    Di Raimondo, Francesco
    Vigneri, Paolo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (03) : 273 - 278
  • [8] Treatment of Chronic Phase Chronic Myeloid Leukemia with Imatinib
    Ganesan, Prasanth
    Rajendranath, Rejiv
    Kandakumar, Vignesh
    Sagar, Tenali Gnana
    INDIAN JOURNAL OF PEDIATRICS, 2015, 82 (03): : 235 - 239
  • [9] Treatment of Chronic Phase Chronic Myeloid Leukemia with Imatinib
    Prasanth Ganesan
    Rejiv Rajendranath
    Vignesh Kandakumar
    Tenali Gnana Sagar
    The Indian Journal of Pediatrics, 2015, 82 : 235 - 239
  • [10] Long-term Treatment of Chronic Myeloid Leukemia
    Yavuz, Akif Selim
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2011, 21 (02): : 10 - 17
12345